membre depuis:
Portefeuille démarré:
Dernière connexion:
10-10-17
12-10-17
05-05-26 10:53
Positions en cours
| Date | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
| 24/02/25 | OSE IMMUNOTHERAPEUTICS | Achat | 500 E | 6.93 | 3.89 | -44.02% | -220 | 
|
0 |
| 17/12/24 | COGELEC SA | Achat | 500 E | 15.50 | 29.20 | 88.10% | 441 |
|
0 |
| 06/11/24 | MEDINCELL SA | Achat | 400 E | 15.22 | 27.42 | 79.88% | 320 |
|
0 |
| 28/10/24 | VALBIOTIS | Achat | 400 E | 1.27 | 0.89 | -30.01% | -120 |
|
0 |
| 28/10/24 | VALBIOTIS | Achat | 400 E | 1.34 | 0.89 | -33.67% | -135 |
|
0 |
| 22/10/24 | ADOCIA | Achat | 400 E | 8.51 | 4.28 | -49.86% | -199 |
|
0 |
| 21/10/24 | ADOCIA | Achat | 400 E | 7.65 | 4.28 | -44.21% | -177 |
|
0 |
| 02/10/24 | ADVICENNE | Achat | 500 E | 2.25 | 1.11 | -50.82% | -254 |
|
0 |
| 02/10/24 | ADVICENNE | Achat | 400 E | 2.29 | 1.11 | -51.68% | -207 |
|
0 |
| 01/10/24 | ADVICENNE | Achat | 400 E | 1.62 | 1.11 | -31.65% | -127 |
|
0 |
| 30/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 8.11 | 3.89 | -52.18% | -209 |
|
0 |
| 23/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 7.41 | 3.89 | -47.66% | -143 |
|
0 |
| 19/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 7.76 | 3.89 | -50.02% | -200 |
|
0 |
| 17/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 7.24 | 3.89 | -46.42% | -186 |
|
0 |
| 22/08/24 | VALBIOTIS | Achat | 400 E | 1.79 | 0.89 | -50.37% | -201 |
|
0 |
| 05/06/24 | VALBIOTIS | Achat | 400 E | 2.31 | 0.89 | -61.57% | -246 |
|
0 |
| 29/05/24 | ADVICENNE | Achat | 400 E | 2.47 | 1.11 | -55.21% | -221 |
|
0 |
| 29/05/24 | ADVICENNE | Achat | 400 E | 2.54 | 1.11 | -56.44% | -226 |
|
24 |
| 10/05/24 | MEDINCELL SA | Achat | 400 E | 14.96 | 27.42 | 83.01% | 332 |
|
0 |
| 10/05/24 | MEDINCELL SA | Achat | 400 E | 15.10 | 27.42 | 81.31% | 325 |
|
0 |
| 08/04/24 | ADOCIA | Achat | 400 E | 10.38 | 4.28 | -58.91% | -236 |
|
0 |
| 25/03/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 4.57 | 3.89 | -15.06% | -60 |
|
0 |
| 21/03/24 | REWORLD MEDIA | Achat | 400 E | 3.21 | 1.70 | -47.19% | -189 |
|
0 |
| 18/12/23 | INNATE PHARMA | Achat | 400 E | 2.34 | 1.56 | -33.41% | -134 |
|
0 |
| 08/11/23 | VALBIOTIS | Achat | 400 E | 6.46 | 0.89 | -86.32% | -345 |
|
0 |
| 19/09/23 | ADVICENNE | Achat | 500 E | 2.39 | 1.11 | -53.70% | -269 |
|
0 |
| 18/09/23 | ADVICENNE | Achat | 400 E | 2.42 | 1.11 | -54.28% | -217 |
|
0 |
| 14/06/23 | VALBIOTIS | Achat | 400 E | 4.32 | 0.89 | -79.50% | -318 |
|
0 |
| 13/06/23 | INNATE PHARMA | Achat | 400 E | 3.20 | 1.56 | -51.34% | -205 |
|
0 |
| 23/09/21 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 11.16 | 3.89 | -65.28% | -261 |
|
7 |
| 23/09/21 | INNATE PHARMA | Achat | 400 E | 6.15 | 1.56 | -74.73% | -299 |
|
7 |
| 21/09/21 | INNATE PHARMA | Achat | 400 E | 5.92 | 1.56 | -73.74% | -295 |
|
7 |
| 15/04/21 | VALBIOTIS | Achat | 400 E | 7.92 | 0.89 | -88.86% | -355 |
|
7 |
| 14/04/21 | VALBIOTIS | Achat | 400 E | 8.19 | 0.89 | -89.23% | -357 |
|
5 |
| 31/03/21 | ADVICENNE | Achat | 400 E | 12.00 | 1.11 | -90.86% | -363 |
|
7 |
| 16/03/21 | VALBIOTIS | Achat | 400 E | 7.84 | 0.89 | -88.75% | -355 |
|
7 |
| 10/02/21 | VALBIOTIS | Achat | 300 E | 7.56 | 0.89 | -88.33% | -265 |
|
7 |
| 04/02/21 | VALBIOTIS | Achat | 300 E | 6.98 | 0.89 | -87.35% | -262 |
|
4 |
| 21/01/21 | VALBIOTIS | Achat | 300 E | 6.78 | 0.89 | -86.97% | -261 |
|
8 |
| 27/11/20 | INNATE PHARMA | Achat | 300 E | 4.47 | 1.56 | -65.19% | -196 |
|
8 |
| 12/11/20 | INNATE PHARMA | Achat | 300 E | 3.82 | 1.56 | -59.25% | -178 |
|
7 |
| 11/11/20 | INNATE PHARMA | Achat | 300 E | 3.85 | 1.56 | -59.57% | -179 |
|
4 |
| 10/09/20 | INNATE PHARMA | Achat | 300 E | 3.39 | 1.56 | -54.07% | -162 |
|
7 |
| 09/09/20 | INNATE PHARMA | Achat | 300 E | 3.68 | 1.56 | -57.70% | -173 |
|
5 |
| 25/05/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 5.80 | 3.89 | -33.10% | -99 |
|
8 |
| 30/04/20 | ADVICENNE | Achat | 300 E | 8.82 | 1.11 | -87.53% | -263 |
|
6 |
| 24/04/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 5.02 | 3.89 | -22.69% | -68 |
|
7 |
| 23/04/20 | INNATE PHARMA | Achat | 300 E | 6.33 | 1.56 | -75.45% | -226 |
|
7 |
| 21/04/20 | INNATE PHARMA | Achat | 300 E | 6.39 | 1.56 | -75.68% | -227 |
|
7 |
| 20/04/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 4.38 | 3.89 | -11.38% | -34 |
|
6 |
| Enregistrements 1 à 50 sur 54 | |||||||||
Positions soldées
| Date sortie | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
| 09/02/21 | TRILOGIQ SA | Achat | 300 E | 6.75 | 6.80 | 0.54% | 2 |  |
2 |
| 09/02/21 | TRILOGIQ SA | Achat | 300 E | 6.95 | 6.80 | -2.36% | -7 | |
2 |
| 09/02/21 | TRILOGIQ SA | Achat | 300 E | 6.95 | 6.80 | -2.36% | -7 | |
2 |
| 09/02/21 | INNATE PHARMA | Achat | 1 000 E | 4.61 | 4.04 | -14.21% | -142 | |
7 |
| 04/02/21 | MAGILLEM | Achat | 300 E | 14.70 | 20.00 | 35.82% | 107 | |
4 |
| 04/02/21 | MAGILLEM | Achat | 300 E | 14.70 | 20.00 | 35.82% | 107 | |
4 |
| 01/02/21 | EUROFINS SCIENTIFIC SE | Achat | 2 000 E | 67.41 | 80.49 | 17.62% | 352 | |
5 |
| 29/01/21 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 300 E | 7.65 | 8.72 | 13.77% | 41 | |
2 |
| 29/01/21 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 300 E | 5.26 | 8.72 | 65.51% | 197 | |
2 |
| 29/01/21 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 300 E | 10.94 | 8.72 | -20.47% | -61 | |
1 |
| 29/01/21 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 300 E | 7.81 | 8.72 | 11.44% | 34 | |
2 |
| 29/01/21 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 2 000 E | 9.82 | 8.72 | -11.60% | -232 | |
5 |
| 21/01/21 | EUROFINS SCIENTIFIC SE
 |
Achat | 2 000 E | 69.18 | 78.71 | 11.88% | 238 | |
7 |
| 19/01/21 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 300 E | 5.25 | 10.22 | 94.37% | 283 | |
2 |
| 19/01/21 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 300 E | 5.96 | 10.28 | 72.21% | 217 | |
3 |
| 19/01/21 | MAUNA KEA TECHNOLOGIES | Achat | 300 E | 1.26 | 1.86 | 47.37% | 142 | |
6 |
| 19/01/21 | MAUNA KEA TECHNOLOGIES | Achat | 300 E | 1.00 | 1.86 | 85.71% | 257 | |
4 |
| 19/01/21 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 2 000 E | 7.61 | 10.18 | 32.37% | 647 | |
2 |
| 07/01/21 | MEDIAN TECHNOLOGIES | Achat | 300 E | 4.75 | 7.06 | 48.38% | 145 | |
2 |
| 07/01/21 | MEDIAN TECHNOLOGIES | Achat | 300 E | 7.80 | 7.06 | -9.68% | -29 | |
4 |
| 07/01/21 | MEDIAN TECHNOLOGIES | Achat | 300 E | 7.12 | 7.06 | -1.04% | -3 | |
3 |
| 04/01/21 | EUROFINS SCIENTIFIC SE
|
Achat | 2 000 E | 70.70 | 71.30 | -0.56% | -11 | |
7 |
| 28/12/20 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 1 000 E | 6.41 | 7.72 | 19.00% | 190 | |
2 |
| 08/12/20 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 1 000 E | 6.24 | 8.29 | 31.87% | 319 | |
2 |
| 27/11/20 | INNATE PHARMA | Achat | 1 000 E | 4.14 | 4.53 | 8.88% | 89 | |
6 |
| 27/11/20 | AMU-BX4 AMUNDI CAC40 DAY INV 1 | Achat | 2 000 E | 2.51 | 2.28 | -9.35% | -187 | |
3 |
| 27/11/20 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 2 000 E | 6.47 | 8.13 | 24.92% | 498 | |
2 |
| 20/11/20 | ACTIA GROUP | Achat | 300 E | 2.25 | 2.65 | 17.56% | 53 | |
5 |
| 13/11/20 | INNATE PHARMA | Achat | 2 000 E | 4.13 | 4.05 | -2.14% | -43 | |
6 |
| 13/11/20 | ACTIA GROUP
|
DIV | 0 E | 0.00 | 0.15 | 0.00% | 22 | |
2 |
| 13/11/20 | ACTIA GROUP
|
DIV | 0 E | 0.00 | 0.15 | 0.00% | 21 | |
2 |
| 13/11/20 | ACTIA GROUP
|
DIV | 0 E | 0.00 | 0.15 | 0.00% | 21 | |
1 |
| 13/11/20 | ACTIA GROUP
|
DIV | 0 E | 0.00 | 0.15 | 0.00% | 11 | |
2 |
| 13/11/20 | ACTIA GROUP
|
DIV | 0 E | 0.00 | 0.15 | 0.00% | 20 | |
3 |
| 13/11/20 | ACTIA GROUP
|
DIV | 0 E | 0.00 | 0.15 | 0.00% | 19 | |
3 |
| 13/11/20 | ACTIA GROUP
|
DIV | 0 E | 0.00 | 0.15 | 0.00% | 127 | |
4 |
| 13/11/20 | ACTIA GROUP
|
DIV | 0 E | 0.00 | 0.15 | 0.00% | 66 | |
2 |
| 13/11/20 | ACTIA GROUP
|
DIV | 0 E | 0.00 | 0.15 | 0.00% | 138 | |
7 |
| 12/11/20 | INNATE PHARMA | Achat | 1 000 E | 3.66 | 3.98 | 8.53% | 85 | |
6 |
| 12/11/20 | INNATE PHARMA | Achat | 300 E | 3.75 | 3.93 | 4.60% | 14 | |
5 |
| 11/11/20 | INNATE PHARMA | Achat | 1 000 E | 6.50 | 3.84 | -41.08% | -411 | |
5 |
| 09/11/20 | ACTIA GROUP | Achat | 300 E | 2.02 | 2.28 | 12.66% | 38 | |
3 |
| 05/11/20 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 1 000 E | 6.29 | 6.29 | -0.20% | -2 | |
3 |
| 04/11/20 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 2 000 E | 5.17 | 6.20 | 19.66% | 393 | |
1 |
| 04/11/20 | AMU-BX4 AMUNDI CAC40 DAY INV 1 | Achat | 2 000 E | 3.49 | 3.10 | -11.50% | -230 | |
2 |
| 03/11/20 | AMU-BX4 AMUNDI CAC40 DAY INV 1 | Achat | 2 000 E | 3.53 | 3.23 | -8.83% | -177 | |
2 |
| 02/11/20 | DBV TECHNOLOGIES | Achat | 2 000 E | 4.36 | 4.75 | 8.74% | 175 | |
2 |
| 02/11/20 | DBV TECHNOLOGIES | Achat | 1 000 E | 5.80 | 4.75 | -18.29% | -183 | |
1 |
| 28/10/20 | ACTIA GROUP | Achat | 2 000 E | 2.18 | 1.92 | -12.30% | -246 | |
5 |
| 28/10/20 | ACTIA GROUP | Achat | 2 000 E | 2.36 | 1.93 | -21.31% | -426 | |
2 |
| Enregistrements 501 à 550 sur 1162 | |||||||||